Tetetla-Castro Daniel, Cruz-Martín Guiomar de Jesús, Castro-Ríos Angélica
Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 39, Servicio de Medicina Familiar. Villahermosa, Tabasco, México.
Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 18, Servicio de Medicina Familiar. Villahermosa, Tabasco, México.
Rev Med Inst Mex Seguro Soc. 2024 Jul 1;62(4):e6053. doi: 10.5281/zenodo.11397116.
High blood pressure causes 9.4 million deaths worldwide annually (12.8% of total mortality). With the start of the COVID-19 pandemic and containment measures, the patterns of care for these patients changed.
To evaluate the changes in hypertensive control of patients treated at UMF 18 of Tabasco before and after the appearance of COVID-19.
Retrospective longitudinal observational study that included a random sample of 326 patients. Hypertensive control was evaluated in accordance with the current Clinical Practice Guideline. Information was collected on blood pressure, dyslipidemia, and glycated hemoglobin for diabetics, as well as other clinical variables and sociodemographic information. The proportion of patients who remained in hypertensive control, worsened or never remained in control was compared between the two periods. Associated factors were identified through multinomial regression analysis.
Before the pandemic, in 2020, 79.1% of patients had blood pressure levels under control, by 2021 it dropped to 50%. T2 diabetes comorbidity was the most important risk factor for lack of control, which after the appearance of COVID-19 almost doubled its effect.
A decrease of 29.1% was recorded in compliance with hypertensive control. Groups with greater difficulty in achieving therapeutic goals were identified, highlighting the economically active population.
高血压每年在全球导致940万人死亡（占总死亡率的12.8%）。随着新冠疫情的爆发及防控措施的实施，这些患者的治疗模式发生了变化。
评估塔巴斯科州第18综合医疗单位（UMF 18）在新冠疫情出现前后接受治疗的高血压患者的血压控制情况变化。
回顾性纵向观察研究，纳入326例患者的随机样本。根据现行临床实践指南评估高血压控制情况。收集了糖尿病患者的血压、血脂异常和糖化血红蛋白信息，以及其他临床变量和社会人口学信息。比较两个时期血压保持控制、病情恶化或从未得到控制的患者比例。通过多项回归分析确定相关因素。
在疫情之前的2020年，79.1%的患者血压水平得到控制，到2021年这一比例降至50%。2型糖尿病合并症是血压未得到控制的最重要危险因素，在新冠疫情出现后其影响几乎翻倍。
高血压控制达标率下降了29.1%。确定了在实现治疗目标方面困难较大的群体，其中经济活跃人群尤为突出。
